Vimarsana
Biggest News Aggregation in the World

Page 2 - Amicogen Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Amicogen Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Amicogen Inc Today - Breaking & Trending Today

 - Vimarsana News

Amicogen Inc., a leading biotech company specializing in industrial enzyme production and drug development, has partnered with Lysando, an innovative biotech company with expertise in the development of …

Source: ots.at
Amicogen and Lysando: Novel Approach for the Treatment of Mastitis in Dairy Cows - Vimarsana News

Amicogen and Lysando: Novel Approach for the Treatment of Mastitis in Dairy Cows

TRIESENBERG, Liechtenstein--(BUSINESS WIRE)--#Artilysin--Amicogen, a leading biotech company specializing in industrial enzyme production and drug developme ...

Source: oilnow.gy
Grains fermented by lactic acid-producing Bacillus coagulans could reduce visceral fat - Vimarsana News

Grains fermented by lactic acid-producing Bacillus coagulans could reduce visceral fat

Fermented grains are capable of lowering total fat mass, body weight and waist circumference, suggesting their potential as a functional health food with anti-obesity effects, say Korean researchers.

Yong Chul Shin, Ph.D., is Chief Scientific Officer of Lysando AG - Vimarsana News

Yong Chul Shin, Ph.D., is Chief Scientific Officer of Lysando AG

Lysando AG market leader in the field of antimicrobial proteins is pleased to announce that Dr. Yong Chul Shin has joined the team as CSO in April. Dr. Shin will be responsible for leading the company's

Global Specialty Enzymes Market to Reach $13.6 Billion by 2030 - Vimarsana News

Global Specialty Enzymes Market to Reach $13.6 Billion by 2030

/PRNewswire/ -- The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around...